
|Articles|October 16, 2020
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.